首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1609806

2024-2032 年日本神經調節市場報告（按技術、生物材料、應用和地區）

Japan Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2024-2032

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 117 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2023年日本神經調節IMARC Group規模達3.082億美元。日本老年人口的不斷增加、最新的技術進步、醫療保健支出的增加、對神經調節益處的認知提高、主要市場參與者的強大存在以及優惠報銷政策的推出是推動市場的一些關鍵因素。

神經調節是指透過向神經系統的目標區域傳遞藥物或電劑來改變神經活動的技術。它涵蓋多種類型，包括脊髓刺激、腦部深部刺激、薦神經刺激和周邊神經刺激。神經調節由多個組件組成，例如脈衝產生器、電極和用於編程的手持設備。它提供多種功能，包括微創手術、可自訂的治療設定和即時回饋機制。神經調節廣泛用於治療慢性疼痛、癲癇、運動障礙、精神疾病、偏頭痛和胃腸道問題。它提供標靶治療、與全身給藥相比副作用減少、可逆性以及遠端患者監測的潛力。此外，神經調節還具有多種優勢，例如增強患者依從性、提高生活品質、長期成本效益以及即時調整治療設定的機會。

日本神經調節市場趨勢：

日本老年人口的不斷增加，導致神經系統和慢性疾病的發病率不斷上升，從而推動了市場的成長。此外，最近的技術進步（例如無線神經調節的出現）擴大了該技術的應用，從而推動了市場的成長。除此之外，醫療保健支出的增加和神經學研究的優先化，為市場擴張創造了有利的環境，是另一個成長誘導因素。此外，人們對神經調節益處的認知不斷提高，從而促進了更快的採用率，從而促進了市場的成長。除此之外，日本主要市場參與者的強大影響力和頻繁的產品發布正在刺激市場成長。除此之外，政府醫療保健系統針對神經調節手術推出的優惠報銷政策正在促進市場成長。此外，透過臨床試驗越來越多的證據表明神經調節的功效，進一步證明了該技術的可信度，正在對市場成長產生積極影響。同時，對微創手術的廣泛需求促進了神經調節的應用，支撐了市場的成長。與此一致的是，神經調節領域熟練的醫療保健專業人員數量的不斷增加正在推動市場的成長。此外，用於即時調整和監控的人工智慧（AI）的整合正在為市場成長創造積極的前景。此外，患者對神經調節的依從性和滿意度不斷提高，鼓勵更多轉診，正在加速市場成長。除此之外，主要參與者之間不斷增加的策略合作和收購，以擴大進一步的研究並利用共享的專業知識，正在加強市場的成長。此外，公共和私人對研發（R＆D）活動的投資不斷成長也推動了市場的成長。

日本神經調節市場細分：

技術見解：

內部神經調節
脊髓刺激 (SCS)
深部腦部刺激 (DBS)
迷走神經刺激 (VNS)
薦神經刺激 (SNS)
胃電刺激 (GES)
外部神經調節
經皮電神經刺激 (TENS)
經顱磁刺激 (TMS)
其他

生物材料見解：

金屬生物材料
高分子生物材料
陶瓷生物材料

應用見解：

帕金森氏症
癲癇
沮喪
肌張力失調
疼痛管理
其他

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

到目前為止，日本神經調節市場的表現如何，未來幾年又會如何表現？
COVID-19 對日本神經調節市場有何影響？
日本神經調節市場在技術上的分化是什麼？
日本基於生物材料的神經調節市場的分化是什麼？
日本神經調節市場在應用上的細分如何？
日本神經調節市場價值鏈的各個階段是什麼？
日本神經調節的關鍵促進因素和挑戰是什麼？
日本神經調節市場的結構如何？
日本神經調節市場的競爭程度如何？

本報告回答的關鍵問題：

到目前為止，日本神經調節市場的表現如何，未來幾年又會如何表現？
COVID-19 對日本神經調節市場有何影響？
日本神經調節市場在技術上的分化是什麼？
日本基於生物材料的神經調節市場的分化是什麼？
日本神經調節市場在應用上的細分如何？
日本神經調節市場價值鏈的各個階段是什麼？
日本神經調節的關鍵促進因素和挑戰是什麼？
日本神經調節市場的結構如何？
日本神經調節市場的競爭程度如何？

內部神經調節
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場區隔
  - 脊髓刺激 (SCS)
  - 深部腦部刺激 (DBS)
  - 迷走神經刺激 (VNS)
  - 薦神經刺激 (SNS)
  - 胃電刺激 (GES)
- 市場預測（2024-2032）
外部神經調節
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場區隔
  - 經皮電神經刺激 (TENS)
  - 經顱磁刺激 (TMS)
  - 其他
- 市場預測（2024-2032）

第 7 章：日本神經調節市場 - 分解：生物材料

金屬生物材料
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
高分子生物材料
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
陶瓷生物材料
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 8 章：日本神經調節市場 - 細分：依應用分類

帕金森氏症
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
癲癇
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
沮喪
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
肌張力失調
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
疼痛管理
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
其他
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 9 章：日本神經調節市場 - 競爭格局

概述
市場結構
市場參與者定位
最佳制勝策略
競爭儀表板
公司評估象限

第 10 章：關鍵參與者簡介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 11 章：日本神經調節市場 - 產業分析

促進因素、限制因素和機會
- 概述
- 促進要素
- 限制
- 機會
波特五力分析
- 概述
- 買家的議價能力
- 供應商的議價能力
- 競爭程度
- 新進入者的威脅
- 替代品的威脅
價值鏈分析

第 12 章：附錄

簡介目錄

Product Code: SR112024A19378

Japan neuromodulation market size reached US$ 308.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 925.5 Million by 2032, exhibiting a growth rate (CAGR) of 13.30% during 2024-2032. The rising geriatric population in Japan, recent technological advancements, increasing healthcare expenditure, heightened awareness about the benefits of neuromodulation, strong presence of key market players, and introduction of favorable reimbursement policies represent some of the key factors driving the market.

Neuromodulation refers to a technology involving the modification of nerve activity by delivering pharmaceutical or electrical agents to targeted areas of the nervous system. It encompasses a wide range of types, including spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, and peripheral nerve stimulation. Neuromodulation is comprised of several components, such as a pulse generator, electrodes, and a handheld device for programming. It offers multiple features, including minimally invasive procedures, customizable treatment settings, and real-time feedback mechanisms. Neuromodulation is widely used for treating chronic pain, epilepsy, movement disorders, psychiatric conditions, migraines, and gastrointestinal issues. It offers targeted therapy, reduced side effects as compared to systemic drug administration, reversibility, and the potential for remote patient monitoring. Additionally, neuromodulation provides several advantages, such as enhanced patient compliance, better quality of life, cost-effectiveness in the long run, and the opportunity for real-time adjustments to treatment settings.

Japan Neuromodulation Market Trends:

The rising geriatric population in Japan, contributing to the escalating incidences of neurological and chronic disorders, is propelling the market growth. Additionally, recent technological advancements, such as the advent of wireless neuromodulation, that are expanding the technique's applications are driving the market growth. Besides this, the increasing healthcare spending and the prioritization of neurological research, fostering a conducive environment for market expansion, is acting as another growth-inducing factor. Furthermore, the heightened awareness about the benefits of neuromodulation, which is facilitating faster adoption rates, is catalyzing the market growth. In addition to this, the strong presence of key market players and frequent product launches in Japan is stimulating the market growth. Apart from this, the introduction of favorable reimbursement policies by the government healthcare system for neuromodulation procedures is bolstering the market growth. Moreover, the growing evidence of the efficacy of neuromodulation through clinical trials, lending further credence to the technology, is positively influencing the market growth. Along with this, the widespread demand for minimally invasive procedures, boosting neuromodulation applications, is supporting the market growth. In line with this, the escalating number of skilled healthcare professionals in the field of neuromodulation is driving the market growth. Furthermore, the integration of artificial intelligence (AI) for real-time adjustments and monitoring is creating a positive outlook for the market growth. In addition, the rising patient compliance and satisfaction rates with neuromodulation, encouraging more referrals, is accelerating the market growth. Besides this, the increasing strategic collaborations and acquisitions among key players to expand further research and leverage shared expertise are strengthening the market growth. Additionally, the growing public and private investment in research and development (R&D) activities is fueling the market growth.

Japan Neuromodulation Market Segmentation:

Technology Insights:

Internal Neuromodulation
Spinal Cord Stimulation (SCS)
Deep Brain Stimulation (DBS)
Vagus Nerve Stimulation (VNS)
Sacral Nerve Stimulation (SNS)
Gastric Electrical Stimulation (GES)
External Neuromodulation
Transcutaneous Electrical Nerve Stimulation (TENS)
Transcranial Magnetic Stimulation (TMS)
Others

Biomaterial Insights:

Metallic Biomaterials
Polymeric Biomaterials
Ceramic Biomaterials

Application Insights:

Parkinson's Disease
Epilepsy
Depression
Dystonia
Pain Management
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan neuromodulation market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan neuromodulation market?
What is the breakup of the Japan neuromodulation market on the basis of technology?
What is the breakup of the Japan neuromodulation market on the basis of biomaterial?
What is the breakup of the Japan neuromodulation market on the basis of application?
What are the various stages in the value chain of the Japan neuromodulation market?
What are the key driving factors and challenges in the Japan neuromodulation?
What is the structure of the Japan neuromodulation market and who are the key players?
What is the degree of competition in the Japan neuromodulation market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Neuromodulation Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Neuromodulation Market Landscape

5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)

6 Japan Neuromodulation Market - Breakup by Technology

6.1 Internal Neuromodulation
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2018-2023)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Spinal Cord Stimulation (SCS)
  - 6.1.3.2 Deep Brain Stimulation (DBS)
  - 6.1.3.3 Vagus Nerve Stimulation (VNS)
  - 6.1.3.4 Sacral Nerve Stimulation (SNS)
  - 6.1.3.5 Gastric Electrical Stimulation (GES)
- 6.1.4 Market Forecast (2024-2032)
6.2 External Neuromodulation
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2018-2023)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Transcutaneous Electrical Nerve Stimulation (TENS)
  - 6.2.3.2 Transcranial Magnetic Stimulation (TMS)
  - 6.2.3.3 Others
- 6.2.4 Market Forecast (2024-2032)

7 Japan Neuromodulation Market - Breakup by Biomaterial

7.1 Metallic Biomaterials
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2018-2023)
- 7.1.3 Market Forecast (2024-2032)
7.2 Polymeric Biomaterials
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2018-2023)
- 7.2.3 Market Forecast (2024-2032)
7.3 Ceramic Biomaterials
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2018-2023)
- 7.3.3 Market Forecast (2024-2032)

8 Japan Neuromodulation Market - Breakup by Application

8.1 Parkinson's Disease
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2018-2023)
- 8.1.3 Market Forecast (2024-2032)
8.2 Epilepsy
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2018-2023)
- 8.2.3 Market Forecast (2024-2032)
8.3 Depression
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2018-2023)
- 8.3.3 Market Forecast (2024-2032)
8.4 Dystonia
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2018-2023)
- 8.4.3 Market Forecast (2024-2032)
8.5 Pain Management
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2018-2023)
- 8.5.3 Market Forecast (2024-2032)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2018-2023)
- 8.6.2 Market Forecast (2024-2032)

9 Japan Neuromodulation Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Neuromodulation Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis